Bergstrom Donald A — SEC Form 4 filings

SEC reporting owner CIK 1709772. 23 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2024-01-18 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Relay Therapeutics, Inc. (RLAY)President, R&D2224 legs · 324,587 sh · $3,042,1586
Fusion Pharmaceuticals Inc. (FUSN)Director14

Form 4 filings — Bergstrom Donald A

FiledFormIssuerReported transactionsSource
2026-09-094Relay Therapeutics, Inc. (RLAY)Sale (S): 8,530 @ $18.97EDGAR
2026-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 2,237 @ $18.61EDGAR
2026-07-084Relay Therapeutics, Inc. (RLAY)Sale (S): 8,660 @ $18.71EDGAR
2026-06-244Relay Therapeutics, Inc. (RLAY)Option exercise (M): 93,456 @ $4.12 · Sale (S): 93,456 @ $16.94 · Option exercise (M): 93,456 (derivative) @ $0EDGAR
2026-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,490 @ $14.79EDGAR
2026-01-294Relay Therapeutics, Inc. (RLAY)Sale (S): 18,895 @ $7.62 · Sale (S): 2,686 @ $8.45EDGAR
2026-01-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 575,000 (derivative) @ $0EDGAR
2025-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 30,897 @ $7.29EDGAR
2025-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 4,069 @ $3.74 · Sale (S): 26,701 @ $3.68EDGAR
2025-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 4,090 @ $3.17 · Sale (S): 27,472 @ $3EDGAR
2025-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 986 @ $2.84EDGAR
2025-01-304Relay Therapeutics, Inc. (RLAY)Sale (S): 3,220 @ $4.63 · Grant/award (A): 176,400 @ $0 · Sale (S): 46,407 @ $4.55 · Sale (S): 30,823 @ $4.42EDGAR
2025-01-144Relay Therapeutics, Inc. (RLAY)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2024-12-314Relay Therapeutics, Inc. (RLAY)Sale (S): 657 @ $4.38EDGAR
2024-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 2,688 @ $6.06EDGAR
2024-10-014Relay Therapeutics, Inc. (RLAY)Sale (S): 648 @ $7.51EDGAR
2024-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 2,698 @ $8.85EDGAR
2024-07-014Relay Therapeutics, Inc. (RLAY)Sale (S): 648 @ $6.26EDGAR
2024-06-044Fusion Pharmaceuticals Inc. (FUSN)Disposition to issuer (D): 34,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-04-294Relay Therapeutics, Inc. (RLAY)Sale (S): 2,686 @ $6.38EDGAR
2024-03-294Relay Therapeutics, Inc. (RLAY)Sale (S): 765 @ $7.70EDGAR
2024-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 3,178 @ $9.64EDGAR
2024-01-184Relay Therapeutics, Inc. (RLAY)Grant/award (A): 300,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709772 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →